As a-CTLA4-TGFβRII effectively counteracted tumor-infiltrating Tregs in vivo, we examined its ability to increase tumor-reactive IFNγ expression in T cells and inhibit tumor growth in human melanoma tumor-bearing NSG mice that were immune reconstituted with matched HLA A2+ human BM CD34+ cells. The gene discussed is IFNG; the disease is melanoma.